Assenagon Asset Management S.A. Aclaris Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $54.1 Billion
- Q4 2024
A detailed history of Assenagon Asset Management S.A. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 397,362 shares of ACRS stock, worth $949,695. This represents 0.0% of its overall portfolio holdings.
Number of Shares
397,362
Previous 185,777
113.89%
Holding current value
$949,695
Previous $209,000
371.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ACRS
# of Institutions
83Shares Held
49.4MCall Options Held
30.6KPut Options Held
1K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$34.1 Million9.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.69MShares$11.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.37MShares$8.06 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.01MShares$7.18 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.75MShares$6.58 Million0.11% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $159M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...